Evidence map›Paper›PMID 36660752›Full record

ReviewAdvanced biomedical research2022

A Review of Studies on

Humaira Farooq, Tahmina Monowar, Swe Swe Latt, Suresh V Chinni, Noor Hasliza Zainol, Gokul Shankar Sabesan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advanced biomedical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Identification ofMicrobiology spectrum · 2026
    Article
  2. Enhancing prognostic prediction of invasive candidiasis among cancer patients with a serum C5a-based scoring model.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  3. Journal of fungi (Basel, Switzerland) · 2024
    Review
  4. Antifungal susceptibility, molecular epidemiology, and clinical risk factors ofFrontiers in cellular and infection microbiology · 2024
    Article
  5. Regulatory role of Mss11 inFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Humaira FarooqFaculty of Medicine, AIMST University, Malaysia.
Tahmina MonowarFaculty of Medicine, AIMST University, Malaysia.
Swe Swe LattFaculty of Medicine, RCSI and UCD Malaysia Campus, Penang, Malaysia.
Suresh V ChinniFaculty of Medicine, Bioscience and Nursing MAHASA University, Selangor, Malaysia.
Noor Hasliza ZainolDepartment of Pathology, Hospital Sultan Abdul Halim, Kedah, Malaysia.
Gokul Shankar SabesanFaculty of Medicine, Manipal University College Malaysia, Melaka, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data on the epidemiology and the antifungal susceptibility of

Indexed as

Antifungal drugsCandida infectionsMalaysiaprevalence

Identifiers

PMID36660752
PMCPMC9843594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.